Results 181 to 190 of about 9,412 (255)

Evaluation of the Antifibrotic Effects of Drugs Commonly Used in Inflammatory Intestinal Diseases on In Vitro Intestinal Cellular Models. [PDF]

Int J Mol Sci
Artone S, Ciafarone A, Augello FR, Lombardi F, Cifone MG, Palumbo P, Cinque B, Latella G.   +7 more
europepmc   +1 more source

Perioperative enhanced recovery program implementation improves clinical outcomes in patients with ulcerative colitis after total proctocolectomy with ileal pouch-anal anastomosis. [PDF]

Int J Colorectal Dis
Ding W, Dai Z, Cui L, Wu X, Zhou W, Ding Z, Xu W, Du P.   +7 more
europepmc   +1 more source

Nivolumab-Induced Immune Mediated Colitis Localized to the Distal Colon: Seven Years Into Therapy. [PDF]

Cureus
Nassif CJ, Nassif II, Todorov M.
europepmc   +1 more source

Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients. [PDF]

Front Neurol
Vodă IM, Tiu VE, Răuță L, Ciucur P, Mușuroi AI, Tomescu AF, Humă NL, Dobrițoiu F, Terecoasă E, Negreanu L, Tiu C.   +10 more
europepmc   +1 more source

Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis. [PDF]

Therap Adv Gastroenterol
Sannaa W, Almasry M, Peedikayil M, Grimshaw AA, Attamimi M, AlMutairdi A, Al-Bawardy B.   +6 more
europepmc   +1 more source

Pseudohaematuria Due to Mesalazine: A Case Report. [PDF]

Nephrology (Carlton)
Truong M, Kairaitis L, Castelino RL.
europepmc   +1 more source

Immunotherapy withdrawal by step-down to mesalamine in pediatric patients with ulcerative colitis. [PDF]

JPGN Rep
Szigeti R, Kellermayer R.
europepmc   +1 more source

Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial. [PDF]

BMC Gastroenterol
Masnadi Shirazi K, Nezam Diba M, Masnadi Shirazinezhad A, Nikniaz Z.   +3 more
europepmc   +1 more source